Drug Side Effects
Search
RETIFANLIMAB-DLWR
RETIFANLIMAB-DLWR
was reported 72 times
RETIFANLIMAB-DLWR is most commonly taken among patients reporting these side effects:
#
Side effect
Count
Frequency
0
ANAL CANCER RECURRENT
1
0.0476
1
ANAL SQUAMOUS CELL CARCINOMA
6
0.0195
2
COLOSTOMY INFECTION
1
0.0167
3
ANAL CANCER
5
0.0052
4
NEUROENDOCRINE CARCINOMA OF THE SKIN
1
0.0010
5
SECONDARY ADRENOCORTICAL INSUFFICIENCY
1
0.0007
6
INFUSION SITE INFECTION
1
0.0004
7
JOINT LOCK
1
0.0004
8
THYROIDITIS
1
0.0003
9
AUTOIMMUNE THYROIDITIS
1
0.0003
10
PLATELET COUNT ABNORMAL
1
0.0002
11
METASTASES TO LIVER
2
0.0001
12
DISEASE PROGRESSION
11
0.0001
13
ELECTROLYTE IMBALANCE
1
0.0001
14
COVID-19 PNEUMONIA
1
0.0001
15
POLYNEUROPATHY
1
0.0001
16
HYPERTHYROIDISM
1
0.0001
17
HYPOAESTHESIA ORAL
1
0.0001
18
DRUG ERUPTION
1
0.0001
19
INTESTINAL OBSTRUCTION
2
0.0001
20
MALIGNANT NEOPLASM PROGRESSION
4
0.0000
21
THERAPY CESSATION
2
0.0000
22
SKIN ULCER
1
0.0000
23
TREATMENT NONCOMPLIANCE
2
0.0000
24
DYSSTASIA
1
0.0000
25
PSYCHOTIC DISORDER
1
0.0000
26
NEUROPATHY PERIPHERAL
3
0.0000
27
OFF LABEL USE
25
0.0000
28
THROMBOCYTOPENIA
3
0.0000
29
BLINDNESS
1
0.0000
30
HYPOGLYCAEMIA
1
0.0000
31
CELLULITIS
1
0.0000
32
PLATELET COUNT DECREASED
2
0.0000
33
GENERAL PHYSICAL HEALTH DETERIORATION
2
0.0000
34
BONE PAIN
1
0.0000
35
ANAEMIA
3
0.0000
36
INFUSION RELATED REACTION
1
0.0000
37
NEUTROPENIA
2
0.0000
38
HEPATIC ENZYME INCREASED
1
0.0000
39
MOBILITY DECREASED
1
0.0000
40
DIABETES MELLITUS
1
0.0000
41
DECREASED APPETITE
3
0.0000
42
PRODUCT STORAGE ERROR
1
0.0000
43
GASTROINTESTINAL DISORDER
1
0.0000
44
NASOPHARYNGITIS
2
0.0000
45
BREAST CANCER
1
0.0000
46
PRODUCT DOSE OMISSION ISSUE
3
0.0000
47
CONDITION AGGRAVATED
3
0.0000
48
ILLNESS
1
0.0000
49
OEDEMA PERIPHERAL
1
0.0000
50
PSORIASIS
1
0.0000
51
MALAISE
3
0.0000
52
HYPOAESTHESIA
1
0.0000
53
HOSPITALISATION
1
0.0000
54
URTICARIA
1
0.0000
55
URINARY TRACT INFECTION
1
0.0000
56
COVID-19
1
0.0000
57
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION
1
0.0000
58
NO ADVERSE EVENT
1
0.0000
59
HYPERSENSITIVITY
1
0.0000
60
GAIT DISTURBANCE
1
0.0000
61
ALOPECIA
1
0.0000
62
NAUSEA
4
0.0000
63
DEATH
4
0.0000
64
DEPRESSION
1
0.0000
65
FEELING ABNORMAL
1
0.0000
66
PRODUCT USE IN UNAPPROVED INDICATION
1
0.0000
67
WEIGHT DECREASED
1
0.0000
68
ASTHENIA
1
0.0000
69
ARTHRALGIA
1
0.0000
70
VOMITING
1
0.0000
71
DIARRHOEA
1
0.0000
72
FATIGUE
1
0.0000